JAISIM SHAH

Profile

First Name

: JAISIM

Middle Name

:

Last Name

: SHAH

Related Companies
Titles
Company Name
Related People
EXECUTIVE OFFICER
ZELOS THERAPEUTICS INC
ALEX BARKAS, FARAH CHAMPSI, JEFF COURTNEY, JEFFREY COURTNEY, COLIN GODDARD, DONALD HAYDEN, DAVID KRAUSE, LILY LAM, JOAN LAU, CYNTHIA LAVOIE, BRIAN MACDONALD, ALAN ROEMER, JOSEPH ZAKRZEWSKI
EXECUTIVE OFFICER
ELEVATION PHARMACEUTICALS INC
BRENTON K. AHRENS, CAM L. GARNER, WILLIAM M. GERHART, JAN LESCHLY, HEATH LUKATCH, HEATHER PRESTON, M.D., PRAVIN SONI, PH.D., AHMET TUTUNCU, M.D., PH.D.
EXECUTIVE OFFICER, DIRECTOR
SEMNUR PHARMACEUTICALS, INC.
BRENT AHRENS, EDGAR ENGLEMAN, MAHENDRA G. SHAH, JAMES TOPPER
DIRECTOR
SORRENTO THERAPEUTICS, INC.
EMST-GUNTER AFTING, ERNST-GUENTER AFTING, ERNST-GUNTER AFTING, VOUNG DR. TRIEU, S. JAMES FREEDMAN, CAM GALLAGHER, GLENN L. HALPRYN, JANE H. HSIAO, PH.D., MBA, KIM JANDA, KIM D. JANDA, KIM JANDA, PH.D., HENRY JI, HENRY JI, PH.D., CURTIS LOCKSHIN, CURTIS LOCKSHIN, PH.D., M. SCOTT SALKA, SCOTT M SALKA, ANTONIUS SCHUH, LEWIS J. SHUSTER, GEORGE UY, RICHARD G VINCENT, RICHARD G. VINCENT, DAVID WEBB, ALAN JAY WEISBERG
DIRECTOR
CELULARITY INC.
GERTJAN BARTLEMA, MOHIT BHATIA, HENRY BROCK, DAVID DEMING, PETER DIAMANDIS, JODI GURNEY, NASSIR HABBOUBI, JOHN HAINES, JOHN R. HAINES, ROBERT HARIRI, HENRY JI, JOSEPH KAMINSKI, DAVID LEMUS, KOK THAY LIM, BILL MARIS, ANDREW PECORA, CURTIS QUIGLEY, CARLOS RAMIREZ, JOHN SCULLEY, JOHN SCULLY, TIM SMITH, TIMOTHY SMITH, BETH STEINBRENNER, ANDREW VON ESCHENBACH, BILL WALLER, WILLIAM WALLER, XIAOKUI ZHANG
EXECUTIVE OFFICER, DIRECTOR
SCILEX HOLDING CO
JAY CHUN, DORMAN FOLLOWWILL, HENRY JI, DAVID LEMUS, STEPHEN MA, YUE ALEXANDER WU
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-05
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
$25,000,001 - $100,000,000 
Debt 
2023-09-21 
2018-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-07 
2017-09-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-15 
2013-10-22
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2013-10-21 
2013-08-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-06 
2011-12-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-16 
2010-05-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2010-05-07